The 72-Hour Clock Favors You

Most billing teams file a standard appeal and wait. Thirty days. Sixty days. Sometimes longer. Sometimes multi-block appeals, or three appeals against three denials for the same patient, all stuck in claims purgatory at once. Whatever the case, many appeals hit a wall. They sit. They get discarded.

There are three tools inside the appeals process that can change that dynamic completely and put the insurer on the back foot. Most practices never use them. Payers count on that.

Expedited review

Federal law under the ACA and CMS rules requires payers to complete expedited review within 72 hours when a denial would seriously jeopardize the patient’s life, health or ability to regain maximum function.

Most billing teams think this means acute emergencies only. It does not. Interrupted oncology treatment qualifies. Post-service denials where the authorization already cleared qualify. High-cost infusion denials where the facility fronted the drug cost qualify. The threshold is lower than most people think, and it applies broadly across oncology, infusion, ASC and specialty settings.

The real value is not speed. It is what expedited review forces. Standard appeals go back into the automated systems. The responses are pre-coded and sent in large batches, rarely with a human involved: an automated output fired against the input. That is not a review. That is a loop.

Expedited review breaks the loop. A licensed physician has to personally review the case within 72 hours. Their name is on the decision. They are on record.

Now layer in a correspondence contradiction. The payer’s own authorization confirmed coverage, and its own claims system denied it anyway. You are not asking the medical director to make a new clinical determination. You are asking them to explain why their own systems said two different things about the same patient, on the same drug, on the same day. They are now defending a denial that contradicts their own authorization while explaining on record why this patient doesn’t qualify for expedited review. Most medical directors see the file and know immediately they can’t defend either position.

Peer to peer

A peer to peer is a direct phone call between the treating physician and the payer’s medical director. It exists in virtually every commercial payer’s process, and it is almost never requested.

Every other step in the appeals process keeps the payer inside its automated system. Documents go in, the system processes them, a decision comes out, and nobody at the payer ever has to say anything out loud. Peer to peer removes that cushion.

I suggest requesting a peer to peer if an expedited appeal has failed, and requesting it on an expedited basis as well; many payers are required by their own policy to honor that timeline. The treating physician gets the medical director on the phone, by name. That medical director now has to defend the denial in real time against the physician who treated the patient. No template uphold letter to hide behind, no processing system to route through: specific clinical questions about a specific patient, with a witness on the line.

Upholding a denial in writing costs a medical director nothing. Defending it out loud to a treating oncologist who is asking why their patient’s authorization was approved and their claim denied is a completely different conversation.

Independent Medical Review

IMR is available in most states for certain denial types, and it is almost entirely unused. After internal appeals are exhausted, it lets the patient or provider request review by an independent organization with no financial relationship to the payer. The reviewer is selected by the state, the payer has no influence over who reviews it or what they decide, and in most states the decision is binding.

The payer has upheld the denial twice, and its own medical director signed off. You request IMR. The independent reviewer sees the authorization, the denial and the uphold letters, with no incentive to reach the conclusion the payer’s internal reviewer reached. Then they issue a binding determination.

Payers know a correspondence contradiction looks very different in front of an independent reviewer than it does inside their own process. And IMR request rates are so low that most payers process tens of thousands of denials before seeing one. The moment you file, the case stops being a routine denial and becomes a regulatory proceeding with a binding external outcome. That gets attention inside the payer.

Work them together

These are not three separate options. They are three escalating pressure points, used in sequence.

1. Expedited review, filed immediately on urgent cases. It bypasses the automated loop and puts a physician on record within 72 hours. Combined with a correspondence contradiction, it creates pressure the standard process can’t.

2. Peer to peer, which removes the automated insulation. The medical director has to defend the denial to the treating physician.

3. IMR, the final move: binding external review by an independent physician, with the contradictions front and center.

The standard appeals process was designed by payers to process quickly and return predictable outcomes. These three tools were not designed by payers. They were built by regulators who understood that automated denial systems need external pressure points. Use them.